Abstract
This first international multicenter study evaluated pregnancy outcomes and their influence on disease activity in Asian women with myelin oligodendrocyte glycoprotein-antibody-associated disease (MOGAD) meeting the 2023 diagnostic criteria. Among 318 women with adult-onset MOGAD, 23 pregnancies after disease onset in 18 women were analyzed. Pregnancy outcomes were generally favorable, with most infants born healthy. Relapse rates decreased during pregnancy and returned postpartum. Three-quarters of women with previously monophasic disease transitioned to a relapsing course postpartum, although most attacks during and after pregnancy recovered well. These findings suggest that pregnancy can be considered with appropriate clinical monitoring in women with MOGAD.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
